Protagonist Therapeutics, Inc. (PTGX)
83.94
+0.62
(+0.74%)
USD |
NASDAQ |
Feb 10, 16:00
83.94
0.00 (0.00%)
After-Hours: 16:32
Protagonist Therapeutics Market Cap : 5.247B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 3.873B |
| Johnson & Johnson | 574.15B |
| Glaukos Corp. | 6.497B |
| Krystal Biotech, Inc. | 7.839B |
| TransMedics Group, Inc. | 4.762B |
Market Cap Related Metrics
| PE Ratio | 132.54 |
| PS Ratio | 25.74 |
| Price to Book Value | 8.130 |
| Price to Free Cash Flow | 84.53 |
| Price | 83.94 |
| Earnings Yield | 0.75% |
| Operating PE Ratio | 283.33 |
| Normalized PE Ratio | 132.54 |